The Medical College of Wisconsin received a four-year, $1.1 million grant from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke to study the use of genetically modified adult stem cells to treat neuropathic pain.
Quinn H. Hogan, M.D., professor of anesthesiology and director of pain research, is the principal investigator for the grant. He will collaborate with Hongwei Yu, M.D., M.S., assistant professor of anesthesiology.
Neuropathic pain is a common type of chronic pain often following nerve injury, affecting an estimated two to three percent of the population. The pain is often resistant to the effects of simple painkillers, limiting treatment options.
Using a rat model, Dr. Hogan’s study will test a novel treatment for neuropathic pain that involves genetically modifying adult stem cells derived from the animal’s own bone marrow or fat. These stem cells will be designed to produce painkilling chemicals, and will be implanted at very specific sections of damaged nerve tissue.
Dr. Hogan’s work may lead to the development of a safe, effective and flexible treatment for patients with chronic pain in which their own cells are modified to produce analgesic substances.
Your link to the biggest stories in the suburbs delivered Thursday mornings.
Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter Get the Newsletter!
- MCW researchers to study treatment reporting tools for breast cancer care
- Thanksgiving Day Worship Service
- Wordsworth Trust Curator to Speak at Wisconsin Lutheran College
- Hart Park Fall Clean-up & Weed-out
- MCW enters new era of medical education
- Milwaukee/NARI Suggests Ways to Ensure a Positive Remodeling Experience in 6 Steps
- Medical physicist named 2014 Educator of the Year
- Does breast milk affect necrotizing enterocolitis?
- Holiday Folk Fair International Offers Advance Ticket Purchase Opportunities
- Milwaukee/NARI Offers November 5 Panel Discussion on Refreshing Mudroom and Laundry Room